Home  »  Markets   »  Here is a breakdown of major shareholders in Cerev...

Here is a breakdown of major shareholders in Cerevel Therapeutics Holdings Inc. (NASDAQ: CERE)

Cerevel Therapeutics Holdings Inc. (NASDAQ: CERE) is -10.15% lower on its value in year-to-date trading and has touched a low of $19.86 and a high of $41.46 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CERE stock was last observed hovering at around $29.10 in the last trading session, with the day’s gains setting it 0.03%.

Currently trading at $29.13, the stock is 3.27% and 4.65% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.26 million and changing 0.10% at the moment leaves the stock 0.16% off its SMA200. CERE registered -10.84% loss for a year compared to 6-month gain of 8.25%.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


The stock witnessed a 6.47% loss in the last 1 month and extending the period to 3 months gives it a -9.98%, and is 2.46% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.87% over the week and 6.28% over the month.

Distance from 52-week low is 46.68% and -29.74% from its 52-week high.

Cerevel Therapeutics Holdings Inc. (CERE) Analyst Forecasts

The EPS is expected to grow by 18.10% this year

Cerevel Therapeutics Holdings Inc. (CERE) Top Institutional Holders

The shares outstanding are 152.31M, and float is at 128.77M with Short Float at 4.38%.

Cerevel Therapeutics Holdings Inc. (CERE) Insider Activity

A total of 37 insider transactions have happened at Cerevel Therapeutics Holdings Inc. (CERE) in the last six months, with sales accounting for 17 and purchases happening 20 times. The most recent transaction is an insider sale by Renger John, the company’s Chief Scientific Officer. SEC filings show that Renger John sold 25,000 shares of the company’s common stock on Nov 01 at a price of $30.00 per share for a total of $0.75 million. Following the sale, the insider now owns 2704.0 shares.

Cerevel Therapeutics Holdings Inc. disclosed in a document filed with the SEC on Oct 04 that Renger John (Chief Scientific Officer) sold a total of 25,000 shares of the company’s common stock. The trade occurred on Oct 04 and was made at $30.00 per share for $0.75 million. Following the transaction, the insider now directly holds 2704.0 shares of the CERE stock.

Still, SEC filings show that on Sep 12, PATRICK DEVAL L (Director) disposed off 47,705 shares at an average price of $30.78 for $1.47 million. The insider now directly holds 0 shares of Cerevel Therapeutics Holdings Inc. (CERE).

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts

Receive Best Stock To Trade Before The Opening Bell



100% Free. Stop Anytime. No Spam




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.